Yes, I wondered the same. Looooong overdue. Remember, nobody here even knew about MHRA PIP policy until it was eventually PR'd. Management kept us in the dark on that one too. Add to it they have no cash to run the trial. I'd guess management has decided to wait for the MHRA decision before they spend on a trial. More waiting.
Wondering if you have a clue as to how many juvenile cases of GBM occur in the UK.
Hint: Less than 30.
No patient with close to GTR would bother with the trial as their prognosis is much better with chemo and radiation than those who can't achieve GTR.
There is at least one other pediatric HGG trial running in the UK. Then there's the company's poor history of running trials.
Then there are the oncologists who aren't going to recommend a trial with zero historical data. So you'll end up with a pool potential of 5 patients. But hey, it was a great pump for LP to dump shares.
News 
Market Data 
Discover 
